SNWV (SANUWAVE Health, Inc.) Short-Term Debt to Capital

SANUWAVE Health Inc - graphic logo of issuer SNWV

The Sanuwave Health Inc (SNWV) price chart demonstrates the company's dynamics, where the indicator stands at 2.51. Business development relies on a staff of medtech experts motivated by profit through stock options and the creation of new tissue regeneration methods. Sales growth is driven by clinic demand for non-invasive ulcer healing. Meanwhile, the PACE system with unique attachments creates a high user dependency on proprietary consumables.

Ratio of Short-Term Indebtedness to Capital: SANUWAVE Health (SNWV) for 03/08/2025 - 11/01/2026
Signature product of sanuwave.com

An analyst is evaluating the credit profile of Sanuwave Health Inc. (SNWV) to determine default risks. The current expansion of shockwave systems across US clinics requires a precise balance between debt and equity. The share of short-term loans in capital measures the dependence of the financing structure on obligations with maturities exceeding one year relative to shareholder equity. A decrease in this ratio minimizes financial threats but may indicate an insufficient pace of business scaling.

Analysis of competing companies

Short-Term Debt to Capital DXCM|PEN (Penumbra Medical) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital NOVT (Novanta Inc.)|haemonetics.com (HAE) - Current Liabilities to Capital|INSP - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PRCT (PROCEPT BioRobotics Corp)|CNMD: Short-Term Debt to Capital|Pulse Medical (PLSE) - Short-Term Debt to Capital|Short-Term Debt to Equity InMode Ltd.|picardmedical.com - Current Liabilities to Equity|Short-Term Debt to Capital SRDX|SENS - Current Liabilities to Capital|NeuroPace Corp - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tactile Systems Technology, Inc. TCMD|OM: Short-Term Debt to Equity Ratio|Electromed, Inc. - Short-Term Loans to Capital Ratio|LNSR: Short-Term Debt to Capital|RCEL - Short-Term Debt to Capital Coefficient|PROF (Profound Medical Corp) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Short-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity IceCure Medical ICCM|LUNG - Short-Term Debt to Equity Ratio|TELA Bio Corp - Short-Term Debt to Capital|Current Liabilities to Capital Cytosorbents|SRTS: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio ZYXI|ECOR (electroCore Inc) - Short-Term Debt to Capital|Vicarious Surgical Corp (RBOT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital IINN|Short-Term Debt to Equity Ratio SeaStar Medical Holding Corp. ICU|Short-Term Debt to Capital IRIX (IRIDEX)|Short-Term Debt to Capital Intelligent Bio Solutions Inc INBS|XAIR - Short-Term Debt to Equity|PFSA: Short-Term Debt to Equity|SSKN (strataskinsciences.com) - Short-Term Debt to Equity Ratio|GlucoTrack Inc. - Ratio of Short-Term Indebtedness to Capital|NAOV (NanoVibronix, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital venusconcept.com VERO|Short-Term Debt to Equity Nuwellis (NUWE)|Aethlon Medical Inc (AEMD) - Short-Term Indebtedness to Equity|Asensus Surgical - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Avinger Inc AVGR|BioSig - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient cutera.com CUTR|Know Labs (KNW) - Short-Term Debt to Equity|Current Liabilities to Equity NARI (Inari Medical Inc)|Short-Term Debt to Equity Nevro Corporation|Short-Term Debt to Equity Ratio ReShape Lifesciences Inc (RSLS)|Short-Term Debt to Capital SILK